Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram

Showing results (471-480 of 24,158) with videos related to

Pageof 2,416
Sort By:
The American Journal of the Medical Sciences|July 1, 1992
Current concepts in renovascular hypertensionC V Ram
ACS Medicinal Chemistry Letters|January 15, 2025
Novel Imidazotriazine Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Novel GIPR Antagonists for Treating Obesity and Type 2 Diabetes MellitusRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Substituted Benzimidazole Compounds as TLR9 Inhibitors for Treating Fibrotic Diseases, Particularly Idiopathic Pulmonary FibrosisRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Plasma Kallikrein Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Phenylpiperidine Derivatives as QPCT and QPCTL Inhibitors for Treating Cancer or Fibrotic DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|September 18, 2024
Novel Heteroaryl Fluoroalkenes as DGK Inhibitors for Treating Cancer, Particularly Metastatic MelanomaRam W Sabnis
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Imidazo[4,5-<i>c</i>]pyridine Compounds as TLR7 Agonists for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Bicyclic Amines as CDK2 Inhibitors for Treating Metastatic Breast Cancer or Metastatic Lung CancerRam W Sabnis
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy and HypersomniaRam W Sabnis
Pageof 2,416

Showing results (471-480 of 24,158) with videos related to

Sort By:
Pageof 2,416
The American Journal of the Medical Sciences|July 1, 1992
Current concepts in renovascular hypertensionC V Ram
ACS Medicinal Chemistry Letters|January 15, 2025
Novel Imidazotriazine Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Novel GIPR Antagonists for Treating Obesity and Type 2 Diabetes MellitusRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Substituted Benzimidazole Compounds as TLR9 Inhibitors for Treating Fibrotic Diseases, Particularly Idiopathic Pulmonary FibrosisRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Plasma Kallikrein Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Phenylpiperidine Derivatives as QPCT and QPCTL Inhibitors for Treating Cancer or Fibrotic DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|September 18, 2024
Novel Heteroaryl Fluoroalkenes as DGK Inhibitors for Treating Cancer, Particularly Metastatic MelanomaRam W Sabnis
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Imidazo[4,5-<i>c</i>]pyridine Compounds as TLR7 Agonists for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Bicyclic Amines as CDK2 Inhibitors for Treating Metastatic Breast Cancer or Metastatic Lung CancerRam W Sabnis
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy and HypersomniaRam W Sabnis
Pageof 2,416